Oasmia Pharmaceutical AB | Ownership
Companies that own Oasmia Pharmaceutical AB
Danica Pension Livsforsikrings A/S
8,643,912
4.82%
8,643,912
1.81%
01/31/2018
SEB Investment Management AB
505,794
0.28%
-578,052
0%
12/31/2017
Skandia Investment Management AB
106,143
0.06%
0
0%
07/31/2018
Danske Bank A/S (Investment Management Sweden)
37,638
0.02%
0
0%
09/11/2018
Catella Fondförvaltning AB
22,368
0.01%
0
0%
08/31/2018
Xact Kapitalförvaltning AB
81
0%
-816,221
0%
08/31/2018
| Address |
Vallongatan 1
Uppsala UP 752 28
Sweden
|
|
Employees
|
- |
| Website |
http://www.oasmia.com |
| Updated |
07/08/2019 |
| Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden. |
